These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35839732)

  • 1. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
    Hettmer S; Linardic CM; Kelsey A; Rudzinski ER; Vokuhl C; Selfe J; Ruhen O; Shern JF; Khan J; Kovach AR; Lupo PJ; Gatz SA; Schäfer BW; Volchenboum S; Minard-Colin V; Koscielniak E; Hawkins DS; Bisogno G; Sparber-Sauer M; Venkatramani R; Merks JHM; Shipley J
    Eur J Cancer; 2022 Sep; 172():367-386. PubMed ID: 35839732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.
    Selfe J; Olmos D; Al-Saadi R; Thway K; Chisholm J; Kelsey A; Shipley J
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTium.
    Ferrari A; Orbach D; Sparber-Sauer M; Walterhouse DO; Pajtler KW; Meyer WH; Spunt SL; Weiss AR
    Eur J Cancer; 2022 Jul; 169():10-19. PubMed ID: 35490564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.
    Rudzinski ER; Kelsey A; Vokuhl C; Linardic CM; Shipley J; Hettmer S; Koscielniak E; Hawkins DS; Bisogno G
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28798. PubMed ID: 33306276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
    Shern JF; Selfe J; Izquierdo E; Patidar R; Chou HC; Song YK; Yohe ME; Sindiri S; Wei J; Wen X; Rudzinski ER; Barkauskas DA; Lo T; Hall D; Linardic CM; Hughes D; Jamal S; Jenney M; Chisholm J; Brown R; Jones K; Hicks B; Angelini P; George S; Chesler L; Hubank M; Kelsey A; Gatz SA; Skapek SX; Hawkins DS; Shipley JM; Khan J
    J Clin Oncol; 2021 Sep; 39(26):2859-2871. PubMed ID: 34166060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of extremity rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, the European Pediatric Soft-Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.
    Morris CD; Tunn PU; Rodeberg DA; Terwisscha van Scheltinga S; Binitie O; Godzinski J; Dall'Igna P; Million L; Hawkins DS; Koscielniak E; Bisogno G; Rogers TN
    Pediatr Blood Cancer; 2023 Mar; 70(3):e28608. PubMed ID: 32776456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical management of paratesticular rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, European paediatric Soft tissue sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.
    Rogers TN; Seitz G; Fuchs J; Martelli H; Dasgupta R; Routh JC; Hawkins DS; Koscielniak E; Bisogno G; Rodeberg DA
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28938. PubMed ID: 33522706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
    Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
    J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
    Folpe AL; McKenney JK; Bridge JA; Weiss SW
    Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children's Oncology Group, the European Soft-Tissue Sarcoma Group, and the Cooperative Weichteilsarkom Studiengruppe.
    Lautz TB; Martelli H; Fuchs J; Chargari C; Smeulders N; Granberg CF; Wolden SL; Sparber-Sauer M; Hawkins DS; Bisogno G; Koscielniak E; Rodeberg DA; Seitz G;
    Pediatr Blood Cancer; 2023 May; 70(5):e28601. PubMed ID: 32762004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
    Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
    Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
    Heinz AT; Schönstein A; Ebinger M; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter M; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Ljungman G; Juntti H; Klingebiel T; Koscielniak E; Sparber-Sauer M;
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30707. PubMed ID: 37814424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local control of parameningeal rhabdomyosarcoma: An expert consensus guideline from the International Soft Tissue Sarcoma Consortium (INSTRuCT).
    Casey DL; Mandeville H; Bradley JA; Ter Horst SAJ; Sheyn A; Timmermann B; Wolden SL
    Pediatr Blood Cancer; 2022 Jul; 69(7):e29751. PubMed ID: 35484997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
    Parham DM; Giannikopoulos P
    Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
    Ruymann FB; Grovas AC
    Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology.
    van Ewijk R; Schoot RA; Sparber-Sauer M; Ter Horst SAJ; Jehanno N; Borgwardt L; de Keizer B; Merks JHM; de Luca A; McHugh K; von Kalle T; Schäfer JF; van Rijn RR;
    Pediatr Radiol; 2021 Sep; 51(10):1940-1951. PubMed ID: 34137936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving classification of rhabdomyosarcoma.
    Agaram NP
    Histopathology; 2022 Jan; 80(1):98-108. PubMed ID: 34958505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials.
    Haduong JH; Heske CM; Allen-Rhoades W; Xue W; Teot LA; Rodeberg DA; Donaldson SS; Weiss A; Hawkins DS; Venkatramani R
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29511. PubMed ID: 35129294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.
    Missiaglia E; Williamson D; Chisholm J; Wirapati P; Pierron G; Petel F; Concordet JP; Thway K; Oberlin O; Pritchard-Jones K; Delattre O; Delorenzi M; Shipley J
    J Clin Oncol; 2012 May; 30(14):1670-7. PubMed ID: 22454413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.
    Dehner CA; Rudzinski ER; Davis JL
    Hum Pathol; 2024 May; 147():72-81. PubMed ID: 38135061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.